Name:	radh_CollaborativeArrangementAdditionalPaymentsToBeMadeUponAchievementOfCertainDevelopmentAndCommercializationMilestones
Namespace Prefix:	radh_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Represents the nonrefundable payments made by the entity under the collaborative agreements.

No definition available.

Name:	radh_CollaborativeArrangementNonrefundablePaymentMade
Namespace Prefix:	radh_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Represents the period for payment of royalties after the date of the first commercial sale in such country of any product including the licensed compound.

No definition available.

Name:	radh_CollaborativeArrangementPeriodAfterDateOfFirstCommercialSaleOfProductForPaymentOfRoyalties
Namespace Prefix:	radh_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the royalty as a percentage of net sales of any product by the Company or its sublicensees under the collaborative agreements.

No definition available.

Name:	radh_CollaborativeArrangementRoyaltyRate
Namespace Prefix:	radh_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Represents the number of days prior to closing on which shares issuable was determined based on the U.S. dollar exchange rate for Euro.

No definition available.

Name:	radh_CollaborativeArrangementsDeterminationOfSharesIssuablePriorToNumberOfDaysOfClosing
Namespace Prefix:	radh_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Number of new preferred stock issued by the reporting entity during the period.

No definition available.

Name:	radh_StockIssuedDuringPeriodSharesNewIssuesPreferredStock
Namespace Prefix:	radh_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

Represents the fair value of each share of temporary equity issued by the Company.

No definition available.

Name:	radh_TemporaryEquityIssuanceFairValuePerShare
Namespace Prefix:	radh_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373